Evotec SE (ETR:EVT – Get Free Report) shares were down 4% on Thursday . The company traded as low as €8.04 ($8.29) and last traded at €8.20 ($8.45). Approximately 1,138,303 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,360,000 shares. The stock had previously closed at €8.54 ($8.80).
Evotec Stock Up 2.5 %
The company has a current ratio of 1.83, a quick ratio of 2.97 and a debt-to-equity ratio of 46.81. The stock’s 50-day moving average price is €8.50 and its two-hundred day moving average price is €7.59. The stock has a market capitalization of $1.52 billion, a P/E ratio of -8.90, a P/E/G ratio of 0.98 and a beta of 1.05.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
See Also
- Five stocks we like better than Evotec
- Overbought Stocks Explained: Should You Trade Them?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- With Risk Tolerance, One Size Does Not Fit All
- Nebius Group: The Rising Star in AI Infrastructure
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
